ALMR compared with A: revenue, margins and what each company keeps, and the suppliers and customers both name

ALMRAlamar Biosciences, Inc.

Mkt capRevenueRevenue

AAgilent Technologies, Inc.

Mkt capRevenueRevenue

Compare

ALMRAlamar Biosciences, Inc.

AAgilent Technologies, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

ALMRAlamar Biosciences, Inc.

30.13· pre 29.00· delayed

Mkt cap$1.8BRevenue$34MQ3 FY26Revenue—

AAgilent Technologies, Inc.

175.74· pre 179.51· delayed

Pre-marketNov 4 '26delayed

Mkt cap$48.5BRevenue$1.9BQ3 FY26Revenue$6.9BFY25

Compare

Pre-marketNov 4 '26delayed

ALMRAlamar Biosciences, Inc.

AAgilent Technologies, Inc.

30.13pre 29.00delayed

Price

175.74pre 179.51delayed

$1.8B

Mkt cap

$48.5B

Q3 FY26$34M

Revenue

$1.9BQ3 FY26

—

Revenue

$6.9BFY25

ALMR30.13vsA175.74Pre-marketNov 4 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ALMR: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ALMR 0

None

Shared 0

No disclosed counterparties: ALMR.

Only A 2

ALNYAlnylam Pharmaceuticalscustomer

WGSGeneDxcustomer

Role chip = supplier or customerSource: SEC EDGAR

Price

rebased to 0%

ALMR, solidA, dashed